{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:38:15Z","timestamp":1790872695045,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T00:00:00Z","timestamp":1476316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T00:00:00Z","timestamp":1476316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Bowman-Birk inhibitor (BBI), a soybean-derived protease inhibitor, is known to have anti-inflammatory effect in both <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> systems. Macrophages play a key role in inflammation and immune activation, which is implicated in HIV disease progression. Here, we investigated the effect of BBI on HIV infection of peripheral blood monocyte-derived macrophages. We demonstrated that BBI could potently inhibit HIV replication in macrophages without cytotoxicity. Investigation of the mechanism(s) of BBI action on HIV showed that BBI induced the expression of IFN-\u03b2 and multiple IFN stimulated genes (ISGs), including Myxovirus resistance protein 2 (Mx2), 2\u2032,5\u2032-oligoadenylate synthetase (OAS-1), Virus inhibitory protein (viperin), ISG15 and ISG56. BBI treatment of macrophages also increased the expression of several known HIV restriction factors, including APOBEC3F, APOBEC3G and tetherin. Furthermore, BBI enhanced the phosphorylation of IRF3, a key regulator of IFN-\u03b2. The inhibition of IFN-\u03b2 pathway by the neutralization antibody to type I IFN receptor (Anti-IFNAR) abolished BBI-mediated induction of the anti-HIV factors and inhibition of HIV in macrophages. These findings that BBI could activate IFN-\u03b2-mediated signaling pathway, initialize the intracellular innate immunity in macrophages and potently inhibit HIV at multiple steps of viral replication cycle indicate the necessity to further investigate BBI as an alternative and cost-effective anti-HIV natural product.<\/jats:p>","DOI":"10.1038\/srep34752","type":"journal-article","created":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T09:07:10Z","timestamp":1476349630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages"],"prefix":"10.1038","volume":"6","author":[{"given":"Tong-Cui","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run-Hong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Yin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Zhe","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,13]]},"reference":[{"key":"BFsrep34752_CR1","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/nm1511","volume":"12","author":"JM Brenchley","year":"2006","unstructured":"Brenchley, J. M. et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature medicine 12, 1365\u20131371, doi:10.1038\/nm1511 (2006).","journal-title":"Nature medicine"},{"key":"BFsrep34752_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/QAI.0000000000000823","volume":"71","author":"LY Spencer","year":"2016","unstructured":"Spencer, L. Y. et al. Systemic Immune Activation and HIV Shedding in the Female Genital Tract. Journal of acquired immune deficiency syndromes 71, 155\u2013162, doi:10.1097\/QAI.0000000000000823 (2016).","journal-title":"Journal of acquired immune deficiency syndromes"},{"key":"BFsrep34752_CR3","doi-asserted-by":"crossref","unstructured":"Zevin, A. S., McKinnon, L., Burgener, A. & Klatt, N. R. Microbial translocation and microbiome dysbiosis in HIV-associated immune activation. Current opinion in HIV and AIDS, doi:10.1097\/COH.0000000000000234 (2015).","DOI":"10.1097\/COH.0000000000000234"},{"key":"BFsrep34752_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.clim.2007.08.015","volume":"126","author":"A Boasso","year":"2008","unstructured":"Boasso, A. & Shearer, G. M. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clinical immunology 126, 235\u2013242, doi:10.1016\/j.clim.2007.08.015 (2008).","journal-title":"Clinical immunology"},{"key":"BFsrep34752_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11904-007-0007-8","volume":"4","author":"PW Hunt","year":"2007","unstructured":"Hunt, P. W. Role of immune activation in HIV pathogenesis. Current HIV\/AIDS reports 4, 42\u201347 (2007).","journal-title":"Current HIV\/AIDS reports"},{"key":"BFsrep34752_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11908-005-0050-9","volume":"7","author":"V Appay","year":"2005","unstructured":"Appay, V., Boutboul, F. & Autran, B. The HIV infection and immune activation: \u201cto fight and burn\u201d. Current infectious disease reports 7, 473\u2013479 (2005).","journal-title":"Current infectious disease reports"},{"key":"BFsrep34752_CR7","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1182\/blood-2003-09-3333","volume":"104","author":"SG Deeks","year":"2004","unstructured":"Deeks, S. G. et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104, 942\u2013947, doi:10.1182\/blood-2003-09-3333 (2004).","journal-title":"Blood"},{"key":"BFsrep34752_CR8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s11481-010-9256-1","volume":"6","author":"BD Kuhl","year":"2011","unstructured":"Kuhl, B. D., Cheng, V., Wainberg, M. A. & Liang, C. Tetherin and its viral antagonists. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology 6, 188\u2013201, doi:10.1007\/s11481-010-9256-1 (2011).","journal-title":"Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology"},{"key":"BFsrep34752_CR9","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1182\/blood-2012-01-407395","volume":"120","author":"N Nasr","year":"2012","unstructured":"Nasr, N. et al. HIV-1 infection of human macrophages directly induces viperin which inhibits viral production. Blood 120, 778\u2013788, doi:10.1182\/blood-2012-01-407395 (2012).","journal-title":"Blood"},{"key":"BFsrep34752_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1365-2567.2010.03270.x","volume":"131","author":"Y Zhou","year":"2010","unstructured":"Zhou, Y. et al. A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages. Immunology 131, 40\u201349, doi:10.1111\/j.1365-2567.2010.03270.x (2010).","journal-title":"Immunology"},{"key":"BFsrep34752_CR11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.yexmp.2012.09.014","volume":"93","author":"F Safavi","year":"2012","unstructured":"Safavi, F. & Rostami, A. Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases. Experimental and molecular pathology 93, 428\u2013433, doi:10.1016\/j.yexmp.2012.09.014 (2012).","journal-title":"Experimental and molecular pathology"},{"key":"BFsrep34752_CR12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4049\/jimmunol.144.2.480","volume":"144","author":"EC Breen","year":"1990","unstructured":"Breen, E. C. et al. Infection with HIV is associated with elevated IL-6 levels and production. Journal of immunology 144, 480\u2013484 (1990).","journal-title":"Journal of immunology"},{"key":"BFsrep34752_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1006\/clin.1993.1052","volume":"67","author":"F Lacroix","year":"1993","unstructured":"Lacroix, F., Zhao, D. Y., Izaguirre, C. A. & Filion, L. G. Suppression by HIV of IL-1 and IL-6 secretion in accessory cells: AC function defect partially corrected with exogenous IL-1 and IL-6. Clinical immunology and immunopathology 67, 109\u2013116 (1993).","journal-title":"Clinical immunology and immunopathology"},{"key":"BFsrep34752_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1051\/jbio\/2003197030267","volume":"197","author":"X Contreras","year":"2003","unstructured":"Contreras, X., Bennasser, Y., Chazal, N. & Bahraoui, E. HIV-1 Tat induces TNF-alpha production by human monocytes: involvement of calcium and PKC pathways. Journal de la Societe de biologie 197, 267\u2013275 (2003).","journal-title":"Journal de la Societe de biologie"},{"key":"BFsrep34752_CR15","doi-asserted-by":"publisher","first-page":"ii18","DOI":"10.1136\/ard.2004.028209","volume":"63","author":"LH Calabrese","year":"2004","unstructured":"Calabrese, L. H., Zein, N. & Vassilopoulos, D. Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection. Annals of the rheumatic diseases 63 Suppl 2, ii18\u2013ii24, doi:10.1136\/ard.2004.028209 (2004).","journal-title":"Annals of the rheumatic diseases"},{"key":"BFsrep34752_CR16","doi-asserted-by":"publisher","first-page":"999","DOI":"10.4049\/jimmunol.176.2.999","volume":"176","author":"C Rizzi","year":"2006","unstructured":"Rizzi, C. et al. Pertussis toxin B-oligomer suppresses IL-6 induced HIV-1 and chemokine expression in chronically infected U1 cells via inhibition of activator protein 1. Journal of immunology 176, 999\u20131006 (2006).","journal-title":"Journal of immunology"},{"key":"BFsrep34752_CR17","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1023\/A:1026616832119","volume":"44","author":"JH Ware","year":"1999","unstructured":"Ware, J. H., Wan, X. S., Newberne, P. & Kennedy, A. R. Bowman-Birk inhibitor concentrate reduces colon inflammation in mice with dextran sulfate sodium-induced ulcerative colitis. Digestive diseases and sciences 44, 986\u2013990 (1999).","journal-title":"Digestive diseases and sciences"},{"key":"BFsrep34752_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12026-011-8254-6","volume":"51","author":"H Dai","year":"2011","unstructured":"Dai, H., Ciric, B., Zhang, G. X. & Rostami, A. Bowman-Birk Inhibitor attenuates experimental autoimmune encephalomyelitis by delaying infiltration of inflammatory cells into the CNS. Immunologic research 51, 145\u2013152, doi:10.1007\/s12026-011-8254-6 (2011).","journal-title":"Immunologic research"},{"key":"BFsrep34752_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1742-2094-8-15","volume":"8","author":"J Li","year":"2011","unstructured":"Li, J. et al. Soybean-derived Bowman-Birk inhibitor inhibits neurotoxicity of LPS-activated macrophages. Journal of neuroinflammation 8, 15, doi:10.1186\/1742-2094-8-15 (2011).","journal-title":"Journal of neuroinflammation"},{"key":"BFsrep34752_CR20","doi-asserted-by":"publisher","first-page":"11707","DOI":"10.1021\/jf802475z","volume":"56","author":"VP Dia","year":"2008","unstructured":"Dia, V. P., Berhow, M. A. & De Mejiat, E. G. Bowman-Birk Inhibitor and Genistein among Soy Compounds That Synergistically Inhibit Nitric Oxide and Prostaglandin E-2 Pathways in Lipopolysaccharide-Induced Macrophages. Journal of agricultural and food chemistry 56, 11707\u201311717, doi:10.1021\/jf802475z (2008).","journal-title":"Journal of agricultural and food chemistry"},{"key":"BFsrep34752_CR21","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1073\/pnas.89.7.3120","volume":"89","author":"PC Billings","year":"1992","unstructured":"Billings, P. C. & Habres, J. M. A Growth-Regulated Protease Activity That Is Inhibited by the Anticarcinogenic Bowman-Birk Protease Inhibitor. Proceedings of the National Academy of Sciences of the United States of America 89, 3120\u20133124, doi:DOI 10.1073\/pnas.89.7.3120 (1992).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep34752_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jns.2008.04.030","volume":"271","author":"T Touil","year":"2008","unstructured":"Touil, T. et al. Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis. J Neurol Sci 271, 191\u2013202, doi:10.1016\/j.jns.2008.04.030 (2008).","journal-title":"J Neurol Sci"},{"key":"BFsrep34752_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/1352458512451509","volume":"19","author":"F Safavi","year":"2013","unstructured":"Safavi, F., Rasouli, J., Mari, E., Zhang, G. X. & Rostami, A. M. Bowman-Birk protease inhibitor (BBI) induces IL10 production in human T cells and suppresses effector phase of experimental autoimmune encephalomyelitis (EAE) by Tr1 induction. Mult Scler J 19, 233\u2013233 (2013).","journal-title":"Mult Scler J"},{"key":"BFsrep34752_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2012.01.005","volume":"245","author":"H Dai","year":"2012","unstructured":"Dai, H., Ciric, B., Zhang, G. X. & Rostami, A. Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor. Journal of neuroimmunology 245, 1\u20137, doi:10.1016\/j.jneuroim.2012.01.005 (2012).","journal-title":"Journal of neuroimmunology"},{"key":"BFsrep34752_CR25","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni1263","volume":"6","author":"JD Fontenot","year":"2005","unstructured":"Fontenot, J. D., Rasmussen, J. P., Gavin, M. A. & Rudensky, A. Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nature immunology 6, 1142\u20131151, doi:10.1038\/ni1263 (2005).","journal-title":"Nature immunology"},{"key":"BFsrep34752_CR26","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1161\/ATVBAHA.107.160663","volume":"28","author":"M Abe","year":"2008","unstructured":"Abe, M. et al. Effects of statins on adipose tissue inflammation: their inhibitory effect on MyD88-independent IRF3\/IFN-beta pathway in macrophages. Arteriosclerosis, thrombosis, and vascular biology 28, 871\u2013877, doi:10.1161\/ATVBAHA.107.160663 (2008).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"BFsrep34752_CR27","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cell.2005.08.012","volume":"122","author":"RB Seth","year":"2005","unstructured":"Seth, R. B., Sun, L., Ea, C. K. & Chen, Z. J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122, 669\u2013682, doi:10.1016\/j.cell.2005.08.012 (2005).","journal-title":"Cell"},{"key":"BFsrep34752_CR28","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.4049\/jimmunol.180.3.1382","volume":"180","author":"H Ha","year":"2008","unstructured":"Ha, H. et al. Stimulation by TLR5 modulates osteoclast differentiation through STAT1\/IFN-beta. Journal of immunology 180, 1382\u20131389 (2008).","journal-title":"Journal of immunology"},{"key":"BFsrep34752_CR29","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.4049\/jimmunol.173.2.1033","volume":"173","author":"A Punturieri","year":"2004","unstructured":"Punturieri, A. et al. Specific engagement of TLR4 or TLR3 does not lead to IFN-beta-mediated innate signal amplification and STAT1 phosphorylation in resident murine alveolar macrophages. Journal of immunology 173, 1033\u20131042 (2004).","journal-title":"Journal of immunology"},{"key":"BFsrep34752_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12307-010-0041-8","volume":"3","author":"X Ling","year":"2010","unstructured":"Ling, X. et al. Mesenchymal Stem Cells Overexpressing IFN-beta Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model. Cancer microenvironment: official journal of the International Cancer Microenvironment Society 3, 83\u201395, doi:10.1007\/s12307-010-0041-8 (2010).","journal-title":"Cancer microenvironment: official journal of the International Cancer Microenvironment Society"},{"key":"BFsrep34752_CR31","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1073\/pnas.0510518103","volume":"103","author":"A Okumura","year":"2006","unstructured":"Okumura, A., Lu, G., Pitha-Rowe, I. & Pitha, P. M. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proceedings of the National Academy of Sciences of the United States of America 103, 1440\u20131445, doi:10.1073\/pnas.0510518103 (2006).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep34752_CR32","doi-asserted-by":"publisher","first-page":"9017","DOI":"10.1128\/JVI.01269-14","volume":"88","author":"C Goujon","year":"2014","unstructured":"Goujon, C. et al. Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor. Journal of virology 88, 9017\u20139026, doi:10.1128\/JVI.01269-14 (2014).","journal-title":"Journal of virology"},{"key":"BFsrep34752_CR33","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nature12653","volume":"502","author":"M Kane","year":"2013","unstructured":"Kane, M. et al. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 502, 563\u2013566, doi:10.1038\/nature12653 (2013).","journal-title":"Nature"},{"key":"BFsrep34752_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12542","volume":"502","author":"C Goujon","year":"2013","unstructured":"Goujon, C. et al. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 502, 559\u2013562, doi:10.1038\/nature12542 (2013).","journal-title":"Nature"},{"key":"BFsrep34752_CR35","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1074\/jbc.M806631200","volume":"284","author":"LA Green","year":"2009","unstructured":"Green, L. A., Liu, Y. & He, J. J. Inhibition of HIV-1 infection and replication by enhancing viral incorporation of innate anti-HIV-1 protein A3G: a non-pathogenic Nef mutant-based anti-HIV strategy. The Journal of biological chemistry 284, 13363\u201313372, doi:10.1074\/jbc.M806631200 (2009).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep34752_CR36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cell.2009.08.039","volume":"139","author":"D Perez-Caballero","year":"2009","unstructured":"Perez-Caballero, D. et al. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139, 499\u2013511, doi:10.1016\/j.cell.2009.08.039 (2009).","journal-title":"Cell"},{"key":"BFsrep34752_CR37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrmicro3449","volume":"13","author":"T Doyle","year":"2015","unstructured":"Doyle, T., Goujon, C. & Malim, M. H. HIV-1 and interferons: who\u2019s interfering with whom? Nature reviews. Microbiology 13, 403\u2013413, doi:10.1038\/nrmicro3449 (2015).","journal-title":"Nature reviews. Microbiology"},{"key":"BFsrep34752_CR38","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1189\/jlb.0313158","volume":"94","author":"Y Wang","year":"2013","unstructured":"Wang, Y., Wang, X., Li, J., Zhou, Y. & Ho, W. RIG-I activation inhibits HIV replication in macrophages. Journal of leukocyte biology 94, 337\u2013341, doi:10.1189\/jlb.0313158 (2013).","journal-title":"Journal of leukocyte biology"},{"key":"BFsrep34752_CR39","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1172\/JCI37155","volume":"119","author":"R Besch","year":"2009","unstructured":"Besch, R. et al. Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. The Journal of clinical investigation 119, 2399\u20132411, doi:10.1172\/JCI37155 (2009).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep34752_CR40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.pharmthera.2009.06.012","volume":"124","author":"PM Barral","year":"2009","unstructured":"Barral, P. M. et al. Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity. Pharmacology & therapeutics 124, 219\u2013234, doi:10.1016\/j.pharmthera.2009.06.012 (2009).","journal-title":"Pharmacology & therapeutics"},{"key":"BFsrep34752_CR41","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/intimm\/dxp017","volume":"21","author":"T Kawai","year":"2009","unstructured":"Kawai, T. & Akira, S. The roles of TLRs, RLRs and NLRs in pathogen recognition. International immunology 21, 317\u2013337, doi:10.1093\/intimm\/dxp017 (2009).","journal-title":"International immunology"},{"key":"BFsrep34752_CR42","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1073\/pnas.82.16.5395","volume":"82","author":"J Yavelow","year":"1985","unstructured":"Yavelow, J., Collins, M., Birk, Y., Troll, W. & Kennedy, A. R. Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro. Proceedings of the National Academy of Sciences of the United States of America 82, 5395\u20135399 (1985).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep34752_CR43","unstructured":"Jonathan Yavelow, M. C. & Kenneth A. Beck. Proteases Occurring in the Cell Membrane: A Possible Cell Receptor for the Bowman-Birk Type of Protease Inhibitors. Cancer Research 1598\u20131601 (1987)."},{"key":"BFsrep34752_CR44","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nature protocols 3, 1101\u20131108 (2008).","journal-title":"Nature protocols"},{"key":"BFsrep34752_CR45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1128\/jvi.62.1.139-147.1988","volume":"62","author":"L Ronald","year":"1988","unstructured":"Ronald, L., willey, D. H. S., Laurence, A. L., Theodore, S. T., Patricia, L. E., Bernard, M., Daniel, J. C. & Malcolm, A. M. In Vitro Mutagenesis Identifies a Region within the Envelope Gene of the Human Immunodeficiency Virus That Is Critical for Infectivity. Journal of Virology 62, 139\u2013147 (1988).","journal-title":"Journal of Virology"},{"key":"BFsrep34752_CR46","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1182\/blood-2012-08-450353","volume":"121","author":"J Li","year":"2013","unstructured":"Li, J. et al. Immune activation of human brain microvascular endothelial cells inhibits HIV replication in macrophages. Blood 121, 2934\u20132942, doi:10.1182\/blood-2012-08-450353 (2013).","journal-title":"Blood"},{"key":"BFsrep34752_CR47","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1182\/blood-2008-09-175000","volume":"113","author":"X Wang","year":"2009","unstructured":"Wang, X. et al. Cellular microRNA expression correlates with susceptibility of monocytes\/macrophages to HIV-1 infection. Blood 113, 671\u2013674, doi:10.1182\/blood-2008-09-175000 (2009).","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1038\/srep37383","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T00:00:00Z","timestamp":1482451200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep34752.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep34752","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep34752.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T02:34:22Z","timestamp":1672886062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep34752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,13]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,16]]}},"alternative-id":["BFsrep34752"],"URL":"https:\/\/doi.org\/10.1038\/srep34752","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,13]]},"assertion":[{"value":"3 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2016","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has not been fixed in the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34752"}}